Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 101,379 | $10,408,582 | -25% | 0.62% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 21,779 | $2,236,050 | +2% | 0.06% |
| 3. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 10,950 | $1,124,237 | 0.56% | |
| 4. | Bourgeon Capital John Zaro | 3,445 | $353,747 | -1% | 0.06% |
| 5. | RWC Asset Management Tord Stallvik (Ceo) | 2,238 | $229,775 | +3% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $92.65 | 10,000 | $926,537.00 | 6,751,103 | 2026-04-27 | Filing | |
| $91.50 | 2,200 | $201,300.00 | 2,200 | 2026-04-23 | Filing | |
| $108.33 | 5,033 | $545,238.98 | 6,738,817 | 2026-02-04 | Filing | |
| $109.14 | 4,967 | $542,092.42 | 6,733,784 | 2026-02-04 | Filing | |
| $107.13 | 18,800 | $2,013,966.92 | 216,203 | 2026-01-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $115.58 | 709 | $81,946.22 | 39,164 | 2026-03-02 | Filing | |
| $115.58 | 885 | $102,288.30 | 146,377 | 2026-03-02 | Filing | |
| $115.58 | 1,144 | $132,223.52 | 76,843 | 2026-03-02 | Filing | |
| $115.58 | 613 | $70,850.54 | 104,291 | 2026-03-02 | Filing | |
| $115.58 | 585 | $67,614.30 | 24,628 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,858,443 | $806,826,343 | 3.76% | |
| 2. | 4,429,571 | $454,784,055 | 0.69% | |
| 3. | 3,125,000 | $320,843,750 | 3.96% | |
| 4. | 3,109,726 | $319,275,555 | 0.74% | |
| 5. | 2,043,420 | $209,797,931 | 0.34% |
News See All
10 Best Medical Device Stocks to Invest In Right Now
On April 27, Tom Lee, Fundstrat Capital Chief Investment Officer and Bitmine Immersion Technologies Chairman, appeared on CNBC's ‘Power Lunch’ to discuss the outlook for equity markets.
10 Best Bear Market Stocks to Invest In Right Now
A stock index is considered to be in a bear market when its closing price falls at least 20% from its most recent high. A correction is milder, with losses between 10% and 19.9%.
Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Abbott Laboratories' First Quarter 2026 Earnings Conference Call.
12 Oversold Blue Chip Stocks to Buy According to Analysts
Oversold blue chip stocks are drawing a closer look, but not just because they have fallen.
Jim Cramer's Game Plan for 12 Stocks and His Take on the Market Post Iran-U.S. Ceasefire Talks
In this article, we will look at the stocks on Jim Cramer’s game plan as he shared his take on the market post-Iran-U.S. ceasefire talks.
15 Best Consistent Dividend Stocks to Buy Right Now
According to an April 6 report by CNBC, if the Iran war drags on longer than expected, investors may want to look at defensive stocks that pay dividends, according to Jefferies.
Conservative Stock Portfolio: 7 Best Stocks to Buy Right Now
On March 24, Reuters reported that Barclays raised its 2026 year-end S&P 500 target on the heels of robust corporate earnings, thanks to the broader technology sector and resilience in economic growth...
Abbott (ABT) Stock Rated Buy on Strong Diabetes Trial Results
Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now.
12 Best Most Active Stocks to Buy Right Now
Recent market volatility has unnerved investors, but not all analysts are turning negative just yet.
Hedge Fund Resource Center